ROCKET PHARMACEUTICALS INC (RCKT) Stock Analyst Earnings Estimates
NASDAQ:RCKT - Nasdaq - US77313F1066 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 232,716.82% | N/A 265.23% | N/A 175.08% | N/A 59.75% | N/A 23.74% | N/A 3.90% | N/A -3.21% | N/A 28.54% | |||||||||||
| EBITDA YoY % growth | -7.7M | -20.35M -164.29% | -7.5M 63.14% | -19.57M -160.93% | -70.83M -261.93% | -75.72M -6.90% | -133.15M -75.85% | -161.88M -21.58% | -214.87M -32.73% | -249.361M -16.05% | N/A -10.46% | N/A 23.85% | N/A 54.78% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.7M | -20.4M -164.94% | -7.57M 62.89% | -19.77M -161.16% | -71.16M -259.94% | -76.15M -7.01% | -134.3M -76.36% | -167.25M -24.53% | -221.14M -32.22% | -256.459M -15.97% | N/A -11.06% | N/A 11.38% | N/A 40.13% | N/A 171.50% | N/A 285.83% | N/A 43.39% | N/A 6.37% | N/A 12.03% | N/A 40.80% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -3.56 8.39% | -6.40 -79.78% | N/A | -1.88 | -1.58 15.96% | -2.51 -58.86% | -2.68 -6.77% | -3.29 -22.76% | -2.94 10.64% | N/A 3.41% | N/A 20.07% | N/A 32.37% | N/A 147.84% | N/A 378.47% | N/A 31.71% | N/A -0.68% | N/A 4.07% | N/A 27.19% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.73 -14.43% | -0.71 -8.01% | -0.73 1.96% | -0.58 17.79% | -0.66 9.27% | -0.38 47.06% | -0.18 74.69% | -0.06 89.51% | 0.14 121.49% |
| Revenue Q2Q % growth | 31.926K | 1.817M | 3.338M | 25.41M | 17.302M 54,094.07% | 87.628M 4,722.67% | 123.36M 3,595.63% | 149.98M 490.24% | 185.86M 974.21% |
| EBITDA Q2Q % growth | -74.358M -36.99% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -72.689M -18.43% | -70.887M -5.21% | -73.001M 0.96% | -50.596M 27.12% | -72.75M -0.08% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.71 5.33% | -0.78 | 0.07 | 8.41% |
| Q2 2024 Q2Q % growth | -0.74 9.76% | -0.73 | -0.01 | -1.16% |
| Q1 2024 Q2Q % growth | -0.66 9.59% | -0.69 | 0.03 | 4.96% |
| Q4 2023 Q2Q % growth | -0.64 30.43% | -0.80 | 0.16 | 20.15% |
| Q3 2023 Q2Q % growth | -0.75 13.79% | -0.82 | 0.07 | 9.05% |
| Q2 2023 Q2Q % growth | -0.82 1.20% | -0.81 | -0.01 | -1.76% |
| Q1 2023 Q2Q % growth | -0.73 -8.96% | -0.87 | 0.14 | 15.97% |
| Q4 2022 Q2Q % growth | -0.92 -33.33% | -0.82 | -0.10 | -12.34% |
| Q3 2022 Q2Q % growth | -0.87 -10.13% | -0.81 | -0.06 | -8.07% |
| Q2 2022 Q2Q % growth | -0.83 -50.91% | -0.70 | -0.13 | -19.23% |
| Q1 2022 Q2Q % growth | -0.67 -3.08% | -0.72 | 0.05 | 7.48% |
| Q4 2021 Q2Q % growth | -0.69 36.11% | -0.78 | 0.09 | 11.41% |
| Q3 2021 Q2Q % growth | -0.79 -49.06% | -0.62 | -0.17 | -27.73% |
| Q2 2021 Q2Q % growth | -0.55 -22.22% | -0.66 | 0.11 | 16.93% |
| Q1 2021 Q2Q % growth | -0.65 -44.44% | -0.70 | 0.05 | 7.28% |
| Q4 2020 Q2Q % growth | -1.08 -176.92% | -0.52 | -0.56 | -105.78% |
| Q3 2020 Q2Q % growth | -0.53 -39.47% | -0.47 | -0.06 | -11.85% |
| Q2 2020 Q2Q % growth | -0.45 -18.42% | -0.52 | 0.07 | 12.74% |
| Q1 2020 Q2Q % growth | -0.45 -4.65% | -0.50 | 0.05 | 9.50% |
| Q4 2019 Q2Q % growth | -0.39 | -0.50 | 0.11 | 21.37% |
| Q3 2019 Q2Q % growth | -0.38 | -0.50 | 0.12 | 24.31% |
| Q2 2019 Q2Q % growth | -0.38 | -0.50 | 0.12 | 24.63% |
| Q1 2019 Q2Q % growth | -0.43 | -0.64 | 0.21 | 32.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 719.1K | -719.1K | -100.00% | |
| Q4 2022 Q2Q % growth | 102K | -102K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.5% | 2.5% | 1.18% | 1.71% |
| Revenue | -96.41% | -96.41% | 0% | -99.79% |